Zynerba Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: ZYNE insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.1%.

Top 25 shareholders own 40.62% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.1%	Harmony Biosciences Holdings, Inc.	7,592,498	US$9.9m	0%	no data
8.77%	Beryl Capital Management LLC	4,426,381	US$5.8m	0%	2.6%
4.32%	The Vanguard Group, Inc.	2,179,600	US$2.8m	0%	no data
1.94%	Armando Anido	976,614	US$1.3m	-20.9%	no data
1.47%	BlackRock, Inc.	740,524	US$962.7k	-11.7%	no data
1.43%	ETF Managers Group LLC	723,151	US$940.1k	0%	0.03%
1.37%	Renaissance Technologies LLC	689,713	US$896.6k	21.1%	no data
1.18%	Terri Sebree	596,241	US$775.1k	-23.4%	no data
0.77%	Geode Capital Management, LLC	387,346	US$503.6k	0%	no data
0.75%	James Fickenscher	378,087	US$491.5k	-32.1%	no data
0.49%	Brian Rosenberger	249,559	US$324.4k	6.75%	no data
0.45%	Albert Parker	227,018	US$295.1k	0%	no data
0.44%	Penserra Capital Management LLC	220,858	US$287.1k	0.78%	0.01%
0.25%	Millennium Management LLC	125,835	US$163.6k	-72.4%	no data
0.25%	Two Sigma Advisers, LP	124,000	US$161.2k	-14.4%	no data
0.24%	State Street Global Advisors, Inc.	119,741	US$155.7k	0%	no data
0.23%	Northern Trust Global Investments	115,210	US$149.8k	0%	no data
0.17%	Kenneth Jones	85,520	US$111.2k	0%	no data
0.16%	John Butler	80,765	US$105.0k	144%	no data
0.16%	Bernardo Wealth Planning, LLC	78,578	US$102.2k	104%	0.04%
0.15%	Pamela Stephenson	75,778	US$98.5k	170%	no data
0.15%	Warren Cooper	75,778	US$98.5k	170%	no data
0.15%	Kenneth Moch	75,778	US$98.5k	170%	no data
0.15%	Daniel Kisner	75,778	US$98.5k	170%	no data
0.15%	William Federici	75,778	US$98.5k	170%	no data